General Announcement for PLC

13/11/2017

PROPOSED SUBSCRIPTION OF 2,100,000 NEW ORDINARY SHARES IN CYPRESS MEDIC SDN BHD REPRESENTING 51.03% OF THE ENLARGED SHARE CAPITAL OF CYPRESS MEDIC SDN BHD FOR A CASH CONSIDERATION OF RM1,722,000 ("PROPOSED SUBSCRIPTION")

BCM ALLIANCE BERHAD

Type Reply to Query
Reply to Bursa Malaysia's Query Letter - Reference ID IQL-10112017-00001
Subject PROPOSED SUBSCRIPTION OF 2,100,000 NEW ORDINARY SHARES IN CYPRESS MEDIC SDN BHD REPRESENTING 51.03% OF THE ENLARGED SHARE CAPITAL OF CYPRESS MEDIC SDN BHD FOR A CASH CONSIDERATION OF RM1,722,000 ("PROPOSED SUBSCRIPTION")
Description
BCM ALLIANCE BERHAD (BCM or the COMPANY)

PROPOSED SUBSCRIPTION OF 2,100,000 NEW ORDINARY SHARES IN CYPRESS MEDIC SDN BHD REPRESENTING 51.03% OF THE ENLARGED SHARE CAPITAL OF CYPRESS MEDIC SDN BHD FOR A CASH CONSIDERATION OF RM1,722,000 ("PROPOSED SUBSCRIPTION")
Query Letter Contents

We refer to your Company’s announcement dated 9 November 2017, in respect of the aforesaid matter.

In this connection, kindly furnish Bursa Securities with the following additional information for public release:-

1.        The original cost of investment by the vendors in Cypress Medic Sdn Bhd ("Cypress") and the date of such investment.

2.        Whether the Interested Directors have abstained and will abstain from all deliberations at Board meetings in respect of the Proposed Subscription.

Please furnish Bursa Securities with your reply within one (1) market day from the date hereof.

Yours faithfully,

 

TAN YEW ENG
Vice President, Issuers
Listing, Regulation

TYE/NZ

Cc : Market Surveillance Dept. , Securities Commission (via fax)

(The terms used herein, unless the context otherwise stated, bear the same meaning as those defined in the Company’s announcement made on 9 November 2017 in relation to the Proposed Subscription)

Reference is made to the Company’s announcement made on 9 November 2017.

The Board of Directors of BCM wishes to provide the following additional information:

1.         The original cost of investment by the vendors in Cypress Medic Sdn Bhd (“Cypress”) and the date of such investment

Kindly refer to Appendix I attached for further information.

2.         Whether the Interested Directors have abstained and will abstain from all deliberation at Board meetings in respect of the Proposed Subscription.

The Interested Directors have abstained and will continue to abstain from deliberating and voting on the Proposed Subscription at the relevant Board meeting.

This announcement is dated 13 November 2017.



Please refer attachment below.

Attachments

Appendix I.pdf
142.4 kB



Announcement Info

Company Name BCM ALLIANCE BERHAD
Stock Name BCMALL
Date Announced 13 Nov 2017
Category General Announcement for PLC
Reference Number GA1-13112017-00057


Related Announcements for BCMALL
Date Title
08/08/2022 TRANSACTIONS (CHAPTER 10 OF LISTING REQUIREMENTS) : NON RELATED PARTY TRANSACTIONS BCM ALLIANCE BERHAD ("BCM" OR "THE COMPANY") - SUBSCRIPTION AND ACQUISITION OF 133,700,000 ORDINARY SHARES OF METRONIC GLOBAL BERHAD ("MGB") - DISPOSAL OF 17,200,000 ORDINARY SHARES OF MGB - DISPOSAL OF 33,666,666 WARRANTS B OF MGB
08/08/2022 OTHERS BCM ALLIANCE BERHAD ("BCM") DEALINGS IN QUOTED SECURITIES UNDER RULE 9.20 OF THE ACE MARKET LISTING REQUIREMENTS
13/07/2022 OTHERS BCM ALLIANCE BERHAD ("BCM" OR "THE COMPANY") - SUBSCRIPTION OF AN AGGREGATE OF 101,000,000 RIGHTS SHARES AND EXCESS RIGHTS SHARES OF METRONIC GLOBAL BERHAD ("METRONIC") BY BC MEDICARE SDN. BHD. ("BC MEDICARE"), A WHOLLY-OWNED SUBSIDIARY OF THE COMPANY PURSUANT TO RULE 9.19(26) OF THE ACE MARKET LISTING REQUIREMENTS OF BURSA MALAYSIA SECURITIES BERHAD
25/04/2022 OTHERS BCM ALLIANCE BERHAD ("BCM" OR "THE COMPANY") - PROPOSED AMENDMENTS TO THE CONSTITUTION OF THE COMPANY
01/03/2022 TRANSACTIONS (CHAPTER 10 OF LISTING REQUIREMENTS) : NON RELATED PARTY TRANSACTIONS BCM ALLIANCE BERHAD ("BCM" OR "THE COMPANY") - ACQUISITION OF 4,294,400 ORDINARY SHARES OF BSL CORPORATION BERHAD ("BSL") - DISPOSAL OF 19,849,000 ORDINARY SHARES OF BSL
25/02/2022 TRANSACTIONS (CHAPTER 10 OF LISTING REQUIREMENTS) : NON RELATED PARTY TRANSACTIONS BCM ALLIANCE BERHAD ("BCM" OR "THE COMPANY") - ACQUISITION OF 4,294,400 ORDINARY SHARES OF BSL CORPORATION BERHAD ("BSL") - DISPOSAL OF 19,849,000 ORDINARY SHARES OF BSL
23/02/2022 OTHERS BCM ALLIANCE BERHAD ("BCM" OR "THE COMPANY") - ANNOUNCEMENT PURSUANT TO RULE 9.19(27) OF THE ACE MARKET LISTING REQUIREMENTS OF BURSA MALAYSIA SECURITIES BERHAD
22/02/2022 OTHERS BCM ALLIANCE BERHAD ("BCM") DEALINGS IN QUOTED SECURITIES UNDER RULE 9.20 OF THE ACE MARKET LISTING REQUIREMENTS
12/01/2022 OTHERS BCM ALLIANCE BERHAD ("BCM" OR "THE COMPANY") - OFFER AND GRANT OF OPTIONS UNDER EMPLOYEES' SHARE OPTION SCHEME ("ESOS") OF THE COMPANY
24/12/2021 OTHERS BCM ALLIANCE BERHAD ("BCM" OR "THE COMPANY") - MANUFACTURING AGREEMENT BETWEEN BC MEDICARE SDN. BHD., A WHOLLY-OWNED SUBSIDIARY OF BCM AND RLOOP LIMITED AND EURO-CHINA TECHNOLOGY ACHIEVEMENT TRANSFORMATION (TIANJIN) CO., LTD.